Clinical trial
Use of the Cardioprotectant Dexrazoxane During Congenital Heart Surgery
NCT04997291 is registered in ClinicalTrials.gov with University of Texas at Austin as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Use of the Cardioprotectant Dexrazoxane During Congenital Heart Surgery
- Lead sponsor
- University of Texas at Austin
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- April 9, 2021
- Completion date
- January 31, 2022
- Enrollment
- 12 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.